Research Library

If the country is to be economically successful and democratically viable, it would require learning from past mistakes and developing its significant potential in other economic sectors, writes energy policy fellow Francisco J. Monaldi. Forbes blog: http://bit.ly/2R80KU3.

Social media is becoming more and more a part of the daily political process. From a political science perspective, the ability to capture the ideology of elites and citizens using a common platform greatly helps in answering a very important question: which party’s ideological position is closest to that of its supporters, on a left-right ideology scale? Research scholar Abdullah Aydogan analyzes the tweets of four major Turkish political parties to answer this question in a post for the Baker Institute Blog.

The U.S. prosecution of drug kingpin El Chapo Guzman could open a Pandora’s box that exposes corrupt officials in both countries, writes fellow Gary Hale in the Baker Institute Blog.

Understood in its regional context, Philippines President Rodrigo Duterte’s war on drugs appears to be a continuation rather than a departure from Southeast Asian drug policy.

As the UK digests the domestic implications of the Leave vote, middle class voters across the world's most advanced economies have awoken to three flaws in the standard case for further global integration.

While Mexico may indeed emerge from the recent oil price slump in better shape than most, tinkering with the solid macroeconomic foundations established by the country’s last three administrations could lead to trouble.

High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.

Though authorities have launched a massive manhunt for drug kingpin "El Chapo" Guzman, Mexicans across the board— fed up with their government's inability to function effectively — are on the cusp of a popular revolution that could change the political landscape of the nation.

The 340B Drug Pricing Program, which allows uninsured or low-income patients to buy prescription drugs at discounted prices, is under attack.

Anticipation is growing as India's Prime Minister Narendra Modi prepares to release his government’s annual budget. International economics fellow Russell Green advises Modi to go big.